194 related articles for article (PubMed ID: 32407947)
21. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
Fujimura T; Kawamoto S
Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial.
Pfaar O; Klimek L
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):256-63. PubMed ID: 18426146
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
Cox LS; Casale TB; Nayak AS; Bernstein DI; Creticos PS; Ambroisine L; Melac M; Zeldin RK
J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
[TBL] [Abstract][Full Text] [Related]
24. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.
Sharif H; Singh I; Kouser L; Mösges R; Bonny MA; Karamani A; Parkin RV; Bovy N; Kishore U; Robb A; Katotomichelakis M; Holtappels G; Derycke L; Corazza F; von Frenckell R; Wathelet N; Duchateau J; Legon T; Pirotton S; Durham SR; Bachert C; Shamji MH
J Allergy Clin Immunol; 2019 Sep; 144(3):738-749. PubMed ID: 30844425
[TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
26. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
Murakami D; Kubo K; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163
[TBL] [Abstract][Full Text] [Related]
27. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
Ito Y; Takahashi Y; Fujita T; Fukuyama S
Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
[TBL] [Abstract][Full Text] [Related]
28. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
[TBL] [Abstract][Full Text] [Related]
30. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension.
Worm M; Rak S; Samoliński B; Antila J; Höiby AS; Kruse B; Lipiec A; Rudert M; Valovirta E
Clin Exp Allergy; 2019 Apr; 49(4):516-525. PubMed ID: 30570787
[TBL] [Abstract][Full Text] [Related]
32. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
[TBL] [Abstract][Full Text] [Related]
33. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
35. Phoenix sylvestris Roxb pollen allergy: a 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India.
Chakraborty P; Roy I; Chatterjee S; Chanda S; Gupta-Bharracharya S
J Investig Allergol Clin Immunol; 2006; 16(6):377-84. PubMed ID: 17153886
[TBL] [Abstract][Full Text] [Related]
36. A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen.
Ratner PH; Andrews C; Martin B; Howland W; Desai SY; Huang H; Hinkle J; Bode F
Allergy Asthma Proc; 2012; 33(1):27-35. PubMed ID: 22370531
[TBL] [Abstract][Full Text] [Related]
37. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
39. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.
Ellis AK; Frankish CW; O'Hehir RE; Armstrong K; Steacy L; Larché M; Hafner RP
J Allergy Clin Immunol; 2017 Aug; 140(2):486-496. PubMed ID: 28236469
[TBL] [Abstract][Full Text] [Related]
40. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass.
Bozek A; Kolodziejczyk K; Krajewska-Wojtys A; Jarzab J
Ann Allergy Asthma Immunol; 2016 Feb; 116(2):156-61. PubMed ID: 26815709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
